Jubilant Pharmova Ltd. (JUBLPHARMA): Jubilant Pharmova Share Price rises 6.12% today; stock hits Rs 1,074
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Jubilant Pharmova Share Price moved higher today, with the stock at Rs 1,074, up 6.12% from the previous close of Rs 1,012.05. The company’s market capitalisation stood at Rs 15,971.12 crore, placing the move in a meaningful company-size context for traders tracking Jubilant Pharmova Share Price Today and broader Stock Market Today developments. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers following Jubilant Pharmova Stock News, the key point is the size of the intraday move relative to the prior close and the day’s range. Univest tracks this kind of share price rise with a focus on verified numbers, valuation context and sector comparison rather than speculation.
In session terms, the stock opened at Rs 1,013.15, moved through a low of Rs 1,009.3 and touched a high of Rs 1,074.8, ending very near the upper end of the day’s range. Turnover stood at Rs 1.18 crore. That makes Jubilant Pharmova Share Price Update relevant for investors looking at price action, market cap and the day’s trading band together. Univest is useful here because it keeps the focus on what can be verified from the market data and the company’s financial profile.
Jubilant Pharmova Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,074 |
| Previous Close | Rs 1,012.05 |
| Today's Move | Rs 61.95 (+6.12%) |
| Open | Rs 1,013.15 |
| High | Rs 1,074.8 |
| Low | Rs 1,009.3 |
| Turnover | Rs 1.18 crore |
| Market Capitalisation | Rs 15,971.12 crore |
| Market Cap Category | Mid Cap |
Jubilant Pharmova Ltd. (JUBLPHARMA) rose to Rs 1,074 from the previous close of Rs 1,012.05, a move of Rs 61.95 or 6.12%. The stock opened at Rs 1,013.15, reached a high of Rs 1,074.8, recorded a low of Rs 1,009.3.
Jubilant Pharmova Share Price Today shows a gain of Rs 61.95 over the previous close, or 6.12%, with the stock closing at Rs 1,074 after opening at Rs 1,013.15. The intraday high of Rs 1,074.8 was close to the closing level, while the low of Rs 1,009.3 was only slightly below the open. This session therefore reflects a clear same-day price rise within a relatively tight trading band. For Jubilant Pharmova Share News, the verified facts also show that the stock remained above its opening level through the session and finished well above the prior close. Univest readers often use this section to separate the price move itself from any unverified explanation.
The market update is notable because the move occurred without any supplied company-specific trigger in the dataset. That matters for anyone scanning Stocks in News or Top Gainers Today, because the data supports the move but not a cause. As always, the relevant factual frame is price, day range and turnover, not inference.
Jubilant Pharmova Ltd. (JUBLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,971.12 crore |
| P/E Ratio | 45.78x |
| P/B Ratio | 2.26x |
| ROE | 5.97% |
| ROCE | 8.69% |
| EPS | Rs 22.11 |
| Book Value Per Share | Rs 447.64 |
| Dividend Yield | 0.49% |
Jubilant Pharmova Ltd. (JUBLPHARMA) fundamental metrics show P/E 45.78x, P/B 2.26x, ROE 5.97%, ROCE 8.69%. These figures provide context only and are not a buy or sell signal.
Jubilant Pharmova Ltd. has a market capitalisation of Rs 15971.12 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.78x, P/B at 2.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.97% and ROCE of 8.69%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 22.11, book value per share of Rs 447.64, dividend yield of 0.49%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 45.78x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 2.26x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 5.97% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 8.69% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 15,971.12 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Jubilant Pharmova Ltd. (JUBLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Jubilant Pharmova Ltd. (JUBLPHARMA) has a P/E ratio of 45.78x, which is above the benchmark median of 32.69x, a difference of +40.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Jubilant Pharmova Ltd. (JUBLPHARMA) has a ROE of 5.97%, which is below the benchmark median of 11.78%, a difference of -49.32%. Jubilant Pharmova Ltd. (JUBLPHARMA) has a ROCE of 8.69%, which is below the benchmark median of 13.65%, a difference of -36.34%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Jubilant Pharmova Ltd. (JUBLPHARMA) has a P/E ratio of 45.78x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.97% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 8.69% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Jubilant Pharmova Ltd. (JUBLPHARMA) has a market capitalisation of Rs 15,971.12 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Jubilant Pharmova
- Jubilant Pharmova Share Price rose 6.12% today to Rs 1,074.
- The stock moved from a previous close of Rs 1,012.05 and touched Rs 1,074.8 intraday.
- Market capitalisation stood at Rs 15,971.12 crore, giving the move scale context.
- P/E is 45.78, while P/B is 2.26, which can be compared with the same-industry benchmark on Univest.
- ROE is 5.97 and ROCE is 8.69, both below the industry median shown in the sector snapshot.
About Jubilant Pharmova
Jubilant Pharmova Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is followed on the NSE and BSE by investors who track its Share Price, Stock Price, market capitalisation and financial ratios. In a market note like this, the important point is that the business is being viewed through both its daily share price rise and its longer-term fundamentals. The data supplied for Univest includes earnings-related measures such as EPS, balance-sheet context through book value, and valuation measures such as P/E and P/B.
That combination matters because Jubilant Pharmova Share Price Today is not only a market-move story but also a company profile story. When readers assess Jubilant Pharmova Company News or Jubilant Pharmova Latest News, they can place the day’s gain alongside sector membership, profit metrics and benchmark comparisons. Univest uses this structure to keep the story grounded in verified information rather than in assumptions about catalysts or sentiment.
Track Jubilant Pharmova Share Price on Univest
Use Jubilant Pharmova Ltd. (JUBLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Jubilant Pharmova Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. The platform also helps users follow Jubilant Pharmova Share Price Live, Jubilant Pharmova Market Cap and the stock’s comparison with peers in the Healthcare sector. For those scanning Jubilant Pharmova Share News, Univest keeps the focus on verified data and structured analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Jubilant Pharmova Share Price rise today?
Ans. The data confirms Jubilant Pharmova Share Price rose 6.12% to Rs 1,074 today, but it does not establish a company-specific catalyst. The move is best read through the verified price action, market cap and session range.
What is Jubilant Pharmova Share Price Today?
Ans. Jubilant Pharmova Share Price Today is Rs 1,074. It was up Rs 61.95 from the previous close of Rs 1,012.05, and the intraday high of Rs 1,074.8 was close to the closing level.
What is Jubilant Pharmova’s market capitalisation?
Ans. Jubilant Pharmova’s market capitalisation is Rs 15,971.12 crore. That places the company above the industry median market cap in the supplied benchmark and gives the day’s price rise a useful scale reference.
How is Jubilant Pharmova valued versus the industry benchmark?
Ans. Jubilant Pharmova trades at a P/E of 45.78 and P/B of 2.26. The P/E sits above the same-industry median and slightly above the average, while the P/B is below both benchmark levels.
What do Jubilant Pharmova EPS and book value show?
Ans. EPS is Rs 22.11 and book value is Rs 447.64 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth behind each share for comparison work.
How do ROE and ROCE look for Jubilant Pharmova?
Ans. ROE is 5.97 and ROCE is 8.69. Both are below the same-industry medians in the supplied benchmark, which helps explain why investors compare the stock carefully with peers. ROE stands at 5.97%.
Which peers are useful for Jubilant Pharmova Share Price comparison?
Ans. The supplied peer set includes Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. Their valuation and return ratios provide direct reference points for Jubilant Pharmova Share Price analysis.
Where can investors track Jubilant Pharmova Share Price on Univest?
Ans. Investors can track Jubilant Pharmova Share Price on Univest for live updates, valuation ratios, shareholding pattern, market cap and sector comparisons. The platform keeps the analysis structured around verified market data and company fundamentals.
